Cite
HARVARD Citation
Täubel, J. et al. (2021). Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. European heart journal. pp. 178-188. [Online].